Technical Analysis for DRUG - Bright Minds Biosciences Inc.

Grade Last Price % Change Price Change
D 3.92 -2.00% -0.08
DRUG closed down 2.0 percent on Tuesday, December 7, 2021, on 3 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical DRUG trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction -2.00%
Hot IPO Pullback Bullish Swing Setup 0.77%
Inside Day Range Contraction 0.77%
New 52 Week Closing Low Bearish 2.08%
Hot IPO Pullback Bullish Swing Setup 2.08%
New 52 Week Low Weakness 2.08%
Down 3 Days in a Row Weakness 2.08%
New 52 Week Closing Low Bearish 1.55%
Hot IPO Pullback Bullish Swing Setup 1.55%
Older End-of-Day Signals for DRUG ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 12 hours ago
Down 3% about 12 hours ago
Up 3% about 12 hours ago
Down 2 % about 12 hours ago
Down 1% about 12 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Pain Chemical Compounds Organic Compounds Epilepsy Antidepressants Treatment Of Epilepsy 5 Ht2a Receptor Neurotransmitters University Of Texas Medical Branch

Is DRUG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.95
52 Week Low 3.61
Average Volume 528,376
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 4.19
Average True Range 0.72
ADX 0.0
+DI 11.90
-DI 28.20
Chandelier Exit (Long, 3 ATRs) 6.78
Chandelier Exit (Short, 3 ATRs) 5.78
Upper Bollinger Bands 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line -0.62
MACD Signal Line -0.40
MACD Histogram -0.2241
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.34
Resistance 3 (R3) 4.37 4.25 4.27
Resistance 2 (R2) 4.25 4.15 4.24 4.25
Resistance 1 (R1) 4.09 4.08 4.03 4.06 4.22
Pivot Point 3.97 3.97 3.95 3.96 3.97
Support 1 (S1) 3.81 3.87 3.75 3.78 3.62
Support 2 (S2) 3.69 3.80 3.68 3.59
Support 3 (S3) 3.53 3.69 3.57
Support 4 (S4) 3.50